Fabricant to leave NPA for FDA, CRN’s Shao heading to Herbalife

What is in this article?:

Dietary supplement trade associations to lose two influential senior management members.

Two leading U.S. dietary supplement trade associations will say goodbye to senior members of their team this month. Daniel Fabricant, PhD, vice president of global government and scientific affairs at the Natural Products Association (NPA), announced February 2 that he is leaving NPA at the end of February to join the U.S. Food and Drug Administration (FDA) as the director of the agency’s Division of Dietary Supplement Programs.

This FDA position had been held by Vasilios Frankos, PhD, who left the agency in early 2010 to join the supplement company Herbalife as senior vice president of product compliance and safety.

Herbalife, based in Los Angeles and one of the largest nutritional network marketing companies in the world, will also soon employ Andrew Shao, PhD, senior vice president of scientific and regulatory affairs for the Council for Responsible Nutrition (CRN). Shao will join Herbalife on March 7 as vice president of global product science and safety, serving under Frankos.

Prior to joining CRN in 2005, Shao was a senior scientist at GNC and a member of the research and development team at Kemin Health.

Discuss this Article 1

Anonymous (not verified)
on Feb 2, 2011

Dr. Fabricant, wish you the best at the FDA! Please be the industry advocate, and don't get contaminated by the climate! I was concerned to see your comments on the IV Vitamin C- that was not about "patient safety", it was about attacking safe and effective IV Vitamin C, and other nutrients administered via IV. grandfathred "drugs" as they are known! The FDA makes significant income on "NDAs" - new drug approval fees - and any "grandfathered" items were not bringing them income. It had nothing to do with patient safety - it was about re-classifying these as "unapproved drugs" after DECADES of safe use by doctors trained to administer them! And the cGMP "infractions" posted against one manufacturer of IV nutrients, were the exact same procedures that had been approved by the FDA in 6 previous inspections! It simply caused yet one more California company to lay off manufacturing employees, for no reason other than a sudden and unexpected, unexplained interpretation of industry procedure.

Post new comment
Sign In or register to use your Delicious Living ID
(optional)
Search Recipes
Search our full collection of recipes by entering a recipe name or ingredient

Connect With Us